Date Title
March 29, 2019
Completion of Assets Disposal
   -      Completion of Assets Disposal Released 07:02 29-Mar-2019   RNS Number : 4468U Realm Therapeutics PLC 29 March 2019   Realm Therapeutics plc ("Realm", "Realm Therapeutics" or the "Company")   Completion of Assets Disposal   MALVERN, PA, March 29, 2019 - Realm Therapeutics plc (NASDAQ:
March 26, 2019
Realm Therapeutics - Cancellation of AIM Listing
RNS Number : 9555T Realm Therapeutics PLC 26 March 2019   Realm Therapeutics plc ("Realm", " Realm Therapeutics " or the "Company")   Cancellation of AIM Listing       MALVERN, PA , March 26, 2019 - Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical company with a proprietary
March 25, 2019
Realm Therapeutics - Second Price Monitoring Extn
RNS Number : 9383T Realm Therapeutics PLC 25 March 2019   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.
March 25, 2019
Realm Therapeutics - Price Monitoring Extension
RNS Number : 9375T Realm Therapeutics PLC 25 March 2019   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders
March 15, 2019
Realm Therapeutics - Result of General Meeting
RNS Number : 0645T Realm Therapeutics PLC 15 March 2019   Realm Therapeutics plc   Result of General Meeting   All Resolutions Passed   Reminder: Process to Convert Ordinary Shares into ADSs     MALVERN, PA , March 15, 2019 - Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical
February 27, 2019
Realm Therapeutics - Second Price Monitoring Extn
RNS Number : 3352R Realm Therapeutics PLC 27 February 2019   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.
February 27, 2019
Realm Therapeutics - Price Monitoring Extension
RNS Number : 3333R Realm Therapeutics PLC 27 February 2019   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of
February 21, 2019
Realm Therapeutics - Form 8.3 - Realm Therapeutics plc
RNS Number : 7908Q Realm Therapeutics PLC 21 February 2019   FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of
February 21, 2019
Realm Therapeutics - Holding(s) in Company
RNS Number : 7909Q Realm Therapeutics PLC 21 February 2019   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of
February 21, 2019
Realm Therapeutics - Holding(s) in Company
RNS Number : 7911Q Realm Therapeutics PLC 21 February 2019   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of
Displaying 1 - 10 of 150

Search Investor Relations